BioAge Labs, Inc. Common Stock BIOA
i
Market dataready · fetched 2026-11-11T15:40:12.176Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T15:37:48.237846851Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T15:39:18.025699+00:00
BioAge Labs, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 5.32 | 125.3% | 21.1% | |||
| 35Δ | 5.78 | 138.7% | 19.8% | |||
| 40Δ | 6.23 | 152.1% | 18.5% | |||
| 45Δ | 6.69 | 165.4% | 17.2% | |||
| 50Δ | 7.14 | 178.8% | 15.9% | |||
| 55Δ | 7.59 | 187.3% | 14.4% | |||
| 60Δ | 7.99 | 178.3% | 12.3% | |||
| 65Δ | 5.60 | 263.6% | 29.7% | 8.40 | 169.2% | 10.2% |
| 70Δ | 5.28 | 286.2% | 28.7% | 8.80 | 160.2% | 8.2% |
| 75Δ | 9.21 | 151.1% | 6.1% | |||
| 80Δ | 9.61 | 142.1% | 4.0% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.32
- IV
- 125.3%
- B/E move
- 21.1%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.78
- IV
- 138.7%
- B/E move
- 19.8%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.23
- IV
- 152.1%
- B/E move
- 18.5%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.69
- IV
- 165.4%
- B/E move
- 17.2%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.14
- IV
- 178.8%
- B/E move
- 15.9%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.59
- IV
- 187.3%
- B/E move
- 14.4%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.99
- IV
- 178.3%
- B/E move
- 12.3%
65Δ
- Pseudo strike
- 5.60
- IV
- 263.6%
- B/E move
- 29.7%
- Pseudo strike
- 8.40
- IV
- 169.2%
- B/E move
- 10.2%
70Δ
- Pseudo strike
- 5.28
- IV
- 286.2%
- B/E move
- 28.7%
- Pseudo strike
- 8.80
- IV
- 160.2%
- B/E move
- 8.2%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.21
- IV
- 151.1%
- B/E move
- 6.1%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.61
- IV
- 142.1%
- B/E move
- 4.0%
Options history
Table
| Date | IV (%) |
|---|---|
| 188.20% | |
| 177.33% | |
| 189.82% | |
| 181.23% | |
| 205.65% | |
| 223.51% | |
| 180.70% | |
| 316.82% | |
| 241.05% | |
| 231.95% | |
| 251.87% | |
| 256.18% | |
| 176.16% | |
| 248.81% | |
| 270.80% | |
| 258.45% | |
| 238.52% | |
| 249.43% |
Drug Manufacturers - Specialty & Generic
CGC
Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the…
More →COLL
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
More →CPIX
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and marketing of prescription products for hospital acute care,…
More →CRDL
Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular…
More →CRON
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
More →DERM
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
More →